RnR Market Research Offers “2013 European Infectious Disease Testing Market: France,Germany, Italy, Spain, UK Emerging Opp...
b. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs...
C. Market StructureD. Market Size, Growth and Major SuppliersItalyA. Executive SummaryB. Business EnvironmentC. Market Str...
DiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatechLife TechnologyLonzaNan...
Upcoming SlideShare
Loading in …5
×

2013 France, Germany, Italy, Spain, UK European Infectious Disease Testing Market Opportunities and Business Expansion Strategies

318 views

Published on

This comprehensive European survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
318
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

2013 France, Germany, Italy, Spain, UK European Infectious Disease Testing Market Opportunities and Business Expansion Strategies

  1. 1. RnR Market Research Offers “2013 European Infectious Disease Testing Market: France,Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies”Report at US$ 18500 (Single User License). The report got published in Dec 2012 & contains1600 pages.This unique report provides information not available from any other published source, including volume,sales, and leading supplier shares by test.This comprehensive European survey is designed to assist diagnostics industry executives, as well ascompanies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, inevaluating emerging opportunities and developing effective business strategies. The report provides marketsegmentation analysis of over 70 diseases and viruses in five countries, assessment of emergingtechnologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recentmarket entrants with innovative technologies and products.The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnosticsindustry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forcesbehind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s majorhealth threat and a major factor contributing to the rise in incidence of opportunistic infections; bioterrorism;advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.Although for some infections the etiology is still a mystery, while for others the causative microorganisms arepresent in minute concentrations long before the occurrence of first clinical symptoms, recent advances ingenetic engineering and detection technologies are creating exciting opportunities for highly sensitive,specific and cost-effective products.Get sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=65083Buy Your Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=65083Table Of contentsIntroductionWorldwide Market and Technology OverviewA. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugsd. Adeno-Associated Viruses(AAV)3. Aeromonasa. Background
  2. 2. b. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Testsc. Vaccines and DrugsEtc…B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher,BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other SuppliersC. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherFranceA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersGermanyA. Executive SummaryB. Business Environment
  3. 3. C. Market StructureD. Market Size, Growth and Major SuppliersItalyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersSpainA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersU.K.A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/panelsC. Information TechnologyD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive AssessmentsAbbottAffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedix
  4. 4. DiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatechLife TechnologyLonzaNanogen/ElitechNovartis DiagnosticsOrtho-Clinical DiagnosticsQiagenRocheScienionSequenomSeraCareSiemensTakara BioThermo FisherWallacWakoAppendix: Assumed Currency Exchange RatesFor more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441Website: http://www.rnrmarketresearch.com/

×